It’s official: Valeant Pharmaceuticals International (VRX) plunged 51.5% to $33.51 today, its lowest close since Jan. 5, 2011. To put that in perspective, the company is now valued at $11.4 billion, down from $23.6 billion yesterday. Ouch.
Ryan Remiorz/The Canadian Press via Associated Press
Citigroup credit analysts Murali Ganti and team write that Valeant’s “dismal....More>>>
I love batting my way through the weeds of “junky companies” (or what the market at least perceives as junk), and Martin Midstream (MMLP) fits that profile. The company’s share price has tanked throughout the past several years for a variety of reasons, particularly lackluster management execution and an out-of-whack capital structure compared with peers. Moreover, the dividend....More>>>
Looking at the diary, today is the most important day of the week. The Bank of England and the Swiss National Bank meet. The UK reports retail sales. EMU reports CPI figures. The US reports retail sales, industrial output, and two September Fed surveys. Yet the economic updates are unlikely change sentiment ahead of next week FOMC and BOJ meetings.
The euro has been confined to a $1.1200-$1.1285....More>>>
In this low interest rate environment, dividends are still looking great. After all, the S&P 500 currently yields about 2%, and that is a heck of a lot better than you can get through most savings accounts.
On top of this, dividends do two important things:
First, a generous dividend payment often lowers a stock’s volatility. I’d much rather own a stock that’s....More>>>
When I last wrote about Weyerhaeuser (NYSE:WY), its agreement to acquire Plum Creek Timber was ten days old, and several uncertainties surrounded the company as well as its intended transaction. Both its and Plum Creek’s shares were trading oddly, suggesting that investors expected (implausibly) that the price to which it had already agreed might be raised. In fact, the price distortion that....More>>>
I have sold my shares in my business as part of my plan to retire at 55. I now have to rely on investments alone for income. Selling a business generates money upfront, but then what? I had taken over my own investments from mutual funds in 2009, and I guess that made me lucky rather than good. Since the crash of oil, investing has been a lot less fun and a lot less profitable.
investors looking for high-yield stocks all pretty much want the same thing: A steady cash stream. Maybe that cash stream is used to supplement income, or maybe its a way of using reinvested dividends to build wealth over very long time horizons. Either way, the only way one can do that is to find companies that can reliably pay that high yield dividend.
What do Canadian Venture stocks, Arizona, Private Placements, and gold mines have in common? Well, stand alone, not much, but put the components together and you have a series of non-brokered private placements into Canadian small cap companies that have gold mine properties in Arizona. Hmmm….
This morning Silver Spruce Resources Inc. (TSX: SSE.V,....More>>>
This isn’t my first relationship with Royal Bancshares of Pennsylvania (NASDAQ:RBPAA). A decade or so ago, I bought shares in this regional bank when it paid a 4% dividend and churned out steady, if not spectacular earnings. For a number of years, I was content to toss my dividends back to Royal in return for more shares. My share count grew as did my comfort level with this cozy little investment.....More>>>
President and CEO of Kmg Chemicals Inc (NYSE:KMG) Christopher T. Fraser bought 4,000 shares of KMG on 06/22/2017 at an average price of $46.99 a share. The total cost of this purchase was $187,960.
KMG Chemicals Inc, through its subsidiaries, is engaged in the manufacture, formulation and distribution of specialty chemicals. It sells high purity wet process chemicals to the semiconductor....More>>>
The Canadian energy companies may be out of favor, but that has not stopped several of them from posting decent operating results. Investors can invest in Canadian companies far more cheaply than Permian operators. Yet, the results in Canada appear every bit as competitive. Obsidian Energy (OBE)
Although Arch Capital (NASDAQ:ACGL) remains a very well-regarded insurance company, the last year hasn't been so friendly to this company or its peer group. A lot of contributing factors have been at play, including large cat losses in 2017, rising costs, regulatory/competitive changes and so on